FFG
GSK icon

Frisch Financial Group’s GSK GSK Stock Holding History

Frisch Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,618
Closed -$206K – 156
2021
Q1 		$206K Buy
4,618
+180
+4% +$8.17K 0.07% 144
2020
Q4 		$204K Sell
4,438
-194
-4% -$8.91K 0.07% 131
2020
Q3 		$218K Buy
4,632
+50
+1% +$2.5K 0.09% 98
2020
Q2 		$233K Buy
4,582
+61
+1% +$3.13K 0.11% 82
2020
Q1 		$214K Sell
4,521
-152
-3% -$8.11K 0.12% 94
2019
Q4 		$274K Buy
4,673
+43
+0.9% +$2.39K 0.13% 91
2019
Q3 		$247K Buy
+4,630
New +$238K 0.15% 85
2019
Q2 		– Sell
-3,897
Closed -$204K – 103
2019
Q1 		$204K Sell
3,897
-291
-7% -$14.5K 0.12% 102
2018
Q4 		$200K Buy
+4,188
New +$206K 0.14% 93

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Frisch Financial Group's GSK Position: Q2 2021 in Review

Frisch Financial Group sold out of GSK (GSK) in Q2 2021, closing a stake of 4,618 shares — an estimated $206K sold.

Frisch Financial Group first reported a position in GSK in Q4 2018 and held it in 9 quarters. The position peaked at $274K in Q4 2019. 800 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Frisch Financial Group reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Frisch Financial Group sold 4,618 GSK shares in Q2 2021, an estimated $206K.
  • Frisch Financial Group first reported a position in GSK in Q4 2018 and held it in 9 quarters.
  • Frisch Financial Group's GSK position peaked at $274K in Q4 2019.
  • 800 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Frisch Financial Group's 13F filing for Q2 2021, filed 12 Aug 2021.